SCHEMBL8559230

SCHEMBL8559230

O=[N+]([O-])c1ccc(Sc2ccc3ccccc3n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ RAB9A P51151 4/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ ALDH1A1 P00352 4/20 0.50
▸ LMNA P02545 3/20 0.50
▸ GAA P10253 2/20 0.50
▸ HPGD P15428 1/20 0.50
▸ KDM4E B2RXH2 4/20 0.49
▸ DHFR P00374 1/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MMP2 P08253 3/20 0.44
▸ MMP9 P14780 3/20 0.44
▸ MMP8 P22894 3/20 0.44
▸ MMP13 P45452 2/20 0.44
▸ APP P05067 1/20 0.44
▸ RECQL P46063 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19810722 0.78 MAPT (0.57) MAPTSMN1; SMN2RAB9ANPC1MAPK1
SCHEMBL29980210 0.78 MAPT (0.57) MAPTSMN1; SMN2RAB9ANPC1MAPK1
SCHEMBL2114821 0.78 HPGD (0.58) MAPTSMN1; SMN2RAB9ANPC1HTT
SCHEMBL29980222 0.78 HPGD (0.58) MAPTSMN1; SMN2RAB9ANPC1HTT
SCHEMBL22926811 0.77 ALDH1A1 (0.42) MAPTSMN1; SMN2ALDH1A1LMNAGAA
SCHEMBL19420096 0.77 MAPT (0.58) MAPTSMN1; SMN2MAPK1HTTALDH1A1
SCHEMBL31280487 0.76 SMN1; SMN2 (0.63) MAPTSMN1; SMN2RAB9ANPC1HTT
SCHEMBL8560807 0.76 MAPT (0.58) MAPTSMN1; SMN2RAB9AMAPK1HTT
SCHEMBL3389504 0.76 KDM1A (0.53) MAPTSMN1; SMN2RAB9ANPC1MAPK1
SCHEMBL8737022 0.76 SMN1; SMN2 (0.63) MAPTSMN1; SMN2RAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5814646-A TREATING THE PROGRESSION OF ALZHEIMER'S DISEASE, BRAIN DISORDERS ELI LILLY AND COMPANY (US) 1998-09-29 — — US disclosed
US-5624937-A TREATMENT OF ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1997-04-29 — — US disclosed
Send feedback